Dendreon plunges as Provenge prospects wither
Dendreon Corp (DNDN.O) lost two thirds of its market value on Thursday after abandoning its forecast for its debut drug, prostate cancer vaccine Provenge, shocking its biggest backers on Wall Street.
Reuters
Scientists May Have Found Missing Link to Common Brain Cancer
Two gene mutations in the regions of chromosome 1 (CIC) and 19 (FUBP1) may tip body toward cancer.
In U.S.
Popular heartburn drugs may increase esophageal cancer risk
Drugs such as Nexium, Prilosec and Prevacid that control production of stomach acid and treat heartburn, reflux, peptic ulcers and related conditions are some of the most popular medications on the market.
By David Templeton. The Seattle Times
Are hot dogs as bad as cigarettes?
Hot dogs, yes your kid's favorite food, have come under fire by an advocacy group that promotes a vegan diet, preventative medicine and alternatives to animal research.
By Amy Graff. In San Francisco Chronicle (blog)
Tropics of cancer?
Cancer is sometimes thought of as a disease of wealthier countries, but it is a major cause of morbidity and mortality in poorer ones as well. Indeed, by the end of this decade, about 150 million people worldwide will have cancer, with approximately 60% of them residing in developing countries.
By Henry I Miller. In CNN (blog)
Daughters of BRCA mutation carriers unaware of their breast cancer risk
Adult women whose mothers carried the BRCA1 or BRCA2 mutation are largely unaware that they are at increased risk for breast cancer, according to results from a recent survey.
In HemOncToday
Stomach Cancer Tumors Have Genetic Differences: Researchers
Stomach cancer tumors have genetic differences, which determine how they respond to treatment, researchers have found.
In U.S.
Three new cancer tests are on their way
Three emails dropped into my inbox last week, all of them describing a test – at various stages of research – which, if proved to work, will improve patients’ chances of early diagnosis or more effective, speedier and cheaper forms of treatment.
By Judith Potts. In Telegraph.co.uk (blog)
Care of Cancer Survivors: Oncologists vs Primary Care Docs
The number of cancer survivors in the United States
By Roxanne Nelson. In Medscape
Lancement du site web «ecancerHub» financé par l'UE
Un nouveau site central d'informations vient d'être lancé pour apporter aux malades comme à l'ensemble de la communauté du cancer un accès intégré et ouvert à des informations fiables et de haute qualité.
CORDIS Nouvelles
Cancer: un mal impitoyable
L’actualité des derniers jours nous le rappelle sévèrement, le cancer est un mal impitoyable. De plus en plus de gens en reçoivent le diagnostic, mais, heureusement, bon nombre réussissent à le vaincre.
Canoë
Cancer du sein HER 2+ : une nouvelle arme
Ce produit est destiné aux femmes atteintes d'un cancer HER2+++ mais qui deviennent résistantes à l’herceptine.
Par IsabelleDeLyon. Dans Le Post (Blog)
Le blog d’IsabelleDeLyon : http://isabelledelyon.canalblog.com/profile/487082/index.html
Aucun commentaire:
Enregistrer un commentaire